Plasmid DNA manufacturing capabilities

Plasmid DNA (pDNA) manufacturing capabilities play a pivotal role in revolutionizing fields such as cell and gene therapy (CGT), vaccine development and genetic engineering. The small, circular pieces of DNA have emerged as crucial tools in modern biotechnology, with the quality of pDNA production capable of making or breaking project success. 

ReciBioPharm’s experience and expertise in producing high-quality pDNA can help deliver your mRNA and CGT projects, from pDNA manufacturing to clinical trial and commercialization stages.

To find out more about ReciBioPharm’s pDNA capabilities, read the full one-pager that covers our: 

• Advanced technologies
• State-of-the-art facilities 
• Quality systems
• Collaborative program management 

It highlights our commitment to delivering high-quality plasmid DNA and our ability to support projects from phase 1 to commercialization.